Core Insights - LifeMD, Inc. has expanded its pharmacy capabilities to include advanced non-sterile compounding for oral and topical medications, enhancing its vertically integrated platform to better meet patient needs and improve efficiency [1][3] - The commercial pharmacy, launched in August 2024, can now process up to 5,000 prescriptions daily and formulate customized medications, including allergen-free and combination products [2] - LifeMD's compounding pharmacy operates under the FDA's 503A designation, ensuring adherence to strict quality and safety standards, and is currently licensed in 13 states with plans to expand to all 50 states within the next year [3] Company Overview - LifeMD is a leading provider of virtual primary care, offering telemedicine, laboratory access, and pharmacy services across more than 200 conditions, including men's and women's health, weight management, and hormone therapy [4] - The company utilizes a proprietary digital care platform and a 50-state affiliated medical group to enhance access to high-quality and affordable care [4]
LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale